Drug Type Small molecule drug |
Synonyms BXT 51072, SYI 2074, SYI-2074 + [1] |
Mechanism Cell adhesion molecules inhibitors, GPx stimulants(Glutathione peroxidase stimulants) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H13NSe |
InChIKeyFXRYWOJYVGJZLE-UHFFFAOYSA-N |
CAS Registry173026-17-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Plaque psoriasis | Phase 2 | IL | 01 Nov 2008 | |
Coronary Artery Disease | Phase 2 | US | 01 Jun 2007 | |
Diabetes Mellitus, Type 2 | Phase 2 | US | 01 Jun 2007 | |
Diabetes Mellitus, Noninsulin-Dependent, 2 | Phase 2 | IL | 01 May 2006 | |
Acute Coronary Syndrome | Phase 2 | IL | 01 May 2006 | |
Colitis, Ulcerative | Phase 2 | US | - | |
Colitis, Ulcerative | Phase 2 | - | - | |
Pulmonary Disease, Chronic Obstructive | Phase 1 | US | - | - |
Respiratory Distress Syndrome, Adult | Phase 1 | GB | - | - |
Shock, Septic | Phase 1 | EU | - | - |